30.91
전일 마감가:
$31.20
열려 있는:
$31.21
하루 거래량:
234.20K
Relative Volume:
0.80
시가총액:
$993.19M
수익:
$566.77M
순이익/손실:
$48.16M
주가수익비율:
25.97
EPS:
1.19
순현금흐름:
$274.29M
1주 성능:
-5.85%
1개월 성능:
+3.62%
6개월 성능:
-6.87%
1년 성능:
-4.48%
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
COLL을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
COLL
Collegium Pharmaceutical Inc
|
30.91 | 1.06B | 566.77M | 48.16M | 274.29M | 1.19 |
![]()
ZTS
Zoetis Inc
|
147.37 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.53 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
293.12 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-01-10 | 업그레이드 | Needham | Hold → Buy |
2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
2023-08-25 | 재확인 | Needham | Buy |
2023-05-02 | 재개 | Jefferies | Buy |
2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2021-01-11 | 재확인 | H.C. Wainwright | Buy |
2020-07-14 | 개시 | BWS Financial | Sell |
2020-05-27 | 개시 | Guggenheim | Neutral |
2020-02-19 | 재개 | Jefferies | Buy |
2019-10-30 | 재확인 | Needham | Buy |
2019-05-03 | 재개 | H.C. Wainwright | Buy |
2019-04-12 | 재개 | Janney | Buy |
2019-03-20 | 개시 | SunTrust | Hold |
2019-01-16 | 재확인 | Needham | Buy |
2018-03-08 | 재확인 | H.C. Wainwright | Buy |
2018-02-07 | 재확인 | Needham | Buy |
2017-12-05 | 재확인 | Needham | Buy |
2017-09-11 | 개시 | H.C. Wainwright | Buy |
2017-05-11 | 재확인 | Needham | Buy |
2016-09-13 | 개시 | Gabelli & Co | Buy |
2015-06-01 | 개시 | Jefferies | Buy |
2015-06-01 | 개시 | Needham | Buy |
2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
What analysts say about Collegium Pharmaceutical Inc. stockAccelerated wealth building - Autocar Professional
Collegium Pharmaceutical Inc. Stock Analysis and ForecastFree Stock Market Query - Autocar Professional
What drives Collegium Pharmaceutical Inc. stock priceFree Investment Portfolio Suggestions - PrintWeekIndia
Teacher Retirement System of Texas Decreases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Is Collegium Pharmaceutical Inc. a good long term investmentFree Consultation - Autocar Professional
Is Collegium Pharmaceutical Inc. stock a good hedge against inflationBreakout Confirmation Tool - Newser
What risks could impact Collegium Pharmaceutical Inc. stock performanceFree Investment Community - Newser
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks - Yahoo Finance
What makes Collegium Pharmaceutical Inc. stock price move sharplyMassive Gain Ideas - Newser
How Collegium Pharmaceutical Inc. stock performs during market volatilityBalanced Risk Reward Portfolio - Newser
Why Collegium Pharmaceutical Inc. stock attracts strong analyst attentionMoney Making Low Risk Plans - Newser
(COLL) Technical Pivots with Risk Controls - news.stocktradersdaily.com
8,180 Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Purchased by Allspring Global Investments Holdings LLC - Defense World
Collegium Pharmaceutical (COLL) Soars 1.98% on Strong Q1 Earnings - AInvest
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 19% Impressive? - simplywall.st
Collegium announces $150M share repurchase program - MSN
Share Buyback Plan Authorized by Collegium Pharmaceutical (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q2 2024 Earnings Call Transcript - MSN
Collegium Pharmaceutical authorizes $150 million share repurchase program By Investing.com - Investing.com Nigeria
Collegium Pharma Launches Up To $150 Mln Buyback Program; Stock Up In Pre-market - Nasdaq
Collegium Pharmaceutical authorizes $150 million share repurchase program - Investing.com
Collegium Announces $150 Million Share Repurchase Program - GlobeNewswire
COLL announces $150M share buyback through 2026 – cash-funded | COLL SEC FilingForm 8-K - Stock Titan
Collegium Expands Shareholder Returns With Fresh $150M Stock Buyback After Returning $222M Since 2021 - Stock Titan
Collegium Pharmaceutical (NASDAQ:COLL) Cut to “Buy” at Wall Street Zen - Defense World
How To Trade (COLL) - news.stocktradersdaily.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Lowered by Illinois Municipal Retirement Fund - Defense World
Collegium Pharmaceutical Announces Share Repurchase Program Worth $25 Million - MSN
State of Alaska Department of Revenue Decreases Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
SG Americas Securities LLC Has $426,000 Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Farther Finance Advisors LLC Boosts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Assenagon Asset Management S.A. Sells 47,897 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Rhumbline Advisers Grows Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
How the (COLL) price action is used to our Advantage - news.stocktradersdaily.com
California State Teachers Retirement System Sells 856 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Director’s Bold Move: Major Stock Sale at Collegium Pharmaceutical - TipRanks
COLL Q1 Earnings Call: ADHD Portfolio Drives Growth, Management Details Capital Deployment Priorities - Yahoo Finance
3 of Wall Street’s Favorite Stocks with Mounting Challenges - Yahoo Finance
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Position Boosted by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers - Yahoo Finance
Bank of America Corp DE Reduces Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Two Sigma Investments LP Sells 135,582 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
ProShare Advisors LLC Increases Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) - Defense World
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):